| Literature DB >> 24200149 |
Jean Jacques N Noubiap1, Jobert Richie N Nansseu, Karen K Kengne, Shalom Tchokfe Ndoula, Lucy A Agyingi.
Abstract
BACKGROUND: Hepatitis B virus (HBV) is the most contagious blood borne pathogen. The risk of occupational exposure to HBV among health care workers is a major concern, especially medical trainees. In this study we describe the knowledge of risk factors for HBV infection, history of accidental exposure to blood, awareness of HBV vaccine and the vaccination status among medical students in Cameroon.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24200149 PMCID: PMC3874660 DOI: 10.1186/1472-6920-13-148
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Knowledge of risk factors and HBV vaccination among 111 medical students in Cameroon
| 1. HBV is the most contagious blood-borne pathogen through accidental exposure to blood | 60 (54.1) |
| 2. Contact of healthy skin with infected blood is a risk factor of HBV infection | 103 (92.8) |
| 3. Injury with needle contaminated with infected blood is a risk factor of HBV infection | 107 (96.4) |
| 4. Contact of abraded skin with infected body fluid is a risk factor of HBV infection | 101 (91) |
| 5. Contact of eyes with infected blood is a risk factor of HBV infection | 81 (73) |
| 6. HBV could be transmitted through sexual intercourse | 98 (88) |
| 7. HBV could be transmitted through oro-fecal route | 81 (73) |
| 8. HBV could be transmitted through blood | 110 (99.1) |
| 9. HBV could be transmitted from a mother to his foetus | 90 (81.1) |
| 10. You are at a higher risk of HBV infection than the general population | 87 (78.4) |
| 11. There is a vaccine available against HBV | 108 (97.3) |
| 12. The minimum number of doses for a complete primary HBV vaccination is 3 doses | 61 (55) |
| 13. An immune response test should be done after HBV vaccination | 38 (34.2) |
HBV: hepatitis B virus.
HBV vaccination status according to the demographic and academic characteristics among 111 medical students in Cameroon
| Age (mean ± SD) | 23.1 ± 1.2 | 22.8 ± 1.0 | 23.3 ± 0.97 | NS |
| Gender (% M / F) | 50.9 / 49.1 | 47.1 / 52.9 | 60 / 40 | NS |
| Time of the vaccination | ||||
| Before preclinical years | - | 8 | 3 | NS |
| Before clinical years | - | 23 | 15 | |
| During clinical years | - | 3 | 2 | |
| Academic level | ||||
| Year IV | 15 | 2 | 1 | < 0,001 |
| Year V | 9 | 28 | 11 | |
| Year VI | 33 | 4 | 8 | |
| Sensitized on the importance of the HBV vaccine | ||||
| Yes | 10 | 20 | 17 | < 0,001 |
| No | 47 | 14 | 3 | |
NS: p-value is not significant.